Viewing Study NCT02907918


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-02-25 @ 12:55 AM
Study NCT ID: NCT02907918
Status: TERMINATED
Last Update Posted: 2021-09-29
First Post: 2016-09-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Sponsor:
Organization: